Oliver J. McConnell
Papers
4
Total Citations
162
H-Index
4
About
Oliver J. McConnell is a pharmaceutical scientist specializing in drug discovery optimization, with a particular focus on high-throughput screening methodologies, metabolic stability assessment, and enzymatic transformation technologies. His work sits at the intersection of analytical chemistry, biochemistry, and pharmaceutical development, where he has made meaningful contributions to accelerating the early stages of drug candidate evaluation. McConnell's most impactful contribution is his 2003 paper on optimizing microsomal stability screening assays, which has garnered 137 citations and reflects the field's significant demand for faster, more reliable methods to profile drug discovery candidates. This work helped streamline a critical bottleneck in pharmaceutical pipelines, enabling researchers to assess metabolic stability with greater efficiency and throughput. Beyond metabolic profiling, McConnell has advanced the use of robotic systems paired with supercritical fluid chromatography for rapid enzymatic screening, demonstrating a forward-thinking approach to automation in pharmaceutical research. His 2007 work on chiral ester hydrolysis further highlights his expertise in enzymatic selectivity, where he systematically evaluated thirty-five enzymes to generate chiral intermediates critical to drug synthesis. Together, these contributions mark McConnell as a practical innovator dedicated to making drug discovery faster, smarter, and more efficient.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4